We previously reported that cell-based therapies using isolated hepatocytes including hepatocyte transplantation and liver tissue engineering approaches provide therapeutic benefits to hemophilia. For clinical application of these approaches, it is important to establish an active hepatocyte proliferation system that enables providing a sufficient number of hepatocytes. We also reported that human hepatocytes, which were transplanted into the liver of urokinase-type plasminogen activator transgenic severe combined immunodeficiency (uPA/SCID) mice, were able to proliferate while retaining their ability to produce coagulation factor IX. The objective of this study was to explore the functionalities of other coagulation and anticoagulation factors of the propagated human hepatocytes in uPA/SCID mice. Human hepatocytes were transplanted into the liver of uPA/SCID mice, and the propagation status of human hepatocytes in the mice was monitored by the increase in serum human albumin levels and immunohistochemical evaluation on the liver sections. Using uPA/SCID livers with various stages of human hepatocyte propagation, we analyzed the gene expression levels of coagulation factors (prothrombin, factor VII, factor X, and factor VIII) and anticoagulation factors (protein C and protein S) by real-time polymerase chain reaction (PCR) using human-specific primers. As a result, the total amount of raw messenger RNA expression levels increased in all genes analyzed according to the progress of hepatocyte propagation and proliferation. Except for factor VIII, the gene expression levels of the highly repopulated uPA/SCID mouse livers with human hepatocyte showed higher levels than those of normal human livers, indicating that propagated human hepatocytes in the uPA/SCID system possess full functions to produce most of the coagulation-related factors. The current work demonstrated that human hepatocytes can be propagated in experimental animals while maintaining normal gene expression levels of coagulation-related factors. It could be speculated that the propagated cells serve as a cell source for the treatment of various types of coagulation factor deficiencies.
INTRODUCTION
failure in the production of functional coagulation factor VIII (FVIII) or factor IX (FIX) from the liver. Although the ultimate cure for hemophilia patients could be Production of coagulation and anticoagulation factors is one of the important functions of the liver, and most obtained by liver transplantation (10,13,14), world-wide donor organ shortage is the most critical obstacle. For of these coagulation-related factors are produced by hepatocytes (4, 6, 30, 31, 33) . There are various types of patients with hemophilia and other congenital coagulation factor deficiencies, the elevation of the responsible congenital bleeding disorders that lack a production of coagulation factor in the liver, showing a symptomatic factor level to 1-2% of normal levels can provide a phenotypic change from severe to moderate form, resulting bleeding tendency. Hemophilia A or B is well known as a representative bleeding disorder, which is caused by a in a marked improvement in the symptomology and the 438 TATSUMI ET AL.
quality of life (5) . Cell-based approaches using isolated expression of other coagulation and anticoagulation factors including prothrombin, factor VII, factor VIII, fac-hepatocytes could be a feasible therapeutic option toward these coagulation factor deficiencies (18, 20, 21, 24) . tor X, protein C, and protein. This report documents the first comprehensive analyses of coagulation factor-Proof-of-concept studies for hepatocyte-based approaches have been accomplished in both laboratory animals and related gene expressions during in-mouse propagation status of human hepatocytes. humans. We recently reported that hepatocyte transplantation provided an increase of 1-2% of coagulation MATERIALS AND METHODS activities in a mouse model of hemophilia B, FIXknockout mice (31). We also reported that engineering Animals functional liver tissues beneath the kidney capsule were Recipient uPA/SCID mice were generated at Phoenix able to provide therapeutic effects in the mouse model Bio (Higashihiroshima, Hiroshima, Japan) as described of hemophilia A as well as hemophilia B (20,21). As previously (29) . Genotyping for the presence of uPA reported by Dhawan et al. (7) , hepatocyte transplantation transgene in SCID mice was confirmed by polymerase was also successful in the clinic for the treatment of chain reaction assay of isolated genomic DNA as congenital factor VII deficiency. In utero liver cell transdescribed previously (11, 29) . Experimental protocols plantation was also investigated by Rosen et al. (25) .
were developed in accordance with the guidelines of the They described phenotypic improvements in the mouse local animal committees located at both PhoenixBio and model of factor X deficiency. It is important to note that Nara Medical University. these hepatocyte-based approaches could be employed with a simple procedure and in a less invasive manner Transplantation of Human Hepatocytes compared with organ transplantation (18, 22) .
for Propagation in the uPA/SCID Livers One of the major hurdles in establishing hepatocyte-Human hepatocytes, isolated from a 1-year-old white based approaches is the limited availability of biologimale and a 6-year-old Afro-American female were purcally functional hepatocytes. At present, the number of chased from In Vitro Technologies (Baltimore, MD). donor livers for hepatocyte isolation remains severely
The cryopreserved hepatocytes were thawed and suslimited. In most of cases, donor livers are of marginal pended in transplant medium (9,29). The cell viability quality that makes it difficult to obtain functional hepaof the human hepatocytes was determined to be 64.4% tocytes (23) . An additional issue is that current technoland 49.2% by trypan blue exclusion test, respectively. ogy for hepatocyte primary culture appears to be unable One day prior to the transplantation and 1 week after the to support extensive cell proliferation (19) . Under these transplantation, uPA/SCID mice, 20-30 days old, received circumstances, we previously proposed urokinase-type intraperitoneal injections of 0.1 mg of anti-asialo GM1 plasminogen activator transgenic severe combined immurabbit serum (Wako Pure Chemical Industries, Osaka, nodeficiency (uPA/SCID) mice as a feasible in-mouse Japan) to inhibit recipient natural killer cell activity hepatocyte propagation tool. uPA/SCID mice have a against the transplanted hepatocytes. Viable human feature to develop an active damage of their own hepatic hepatocytes (0.75 × 10 6 ) were transplanted using an parenchymal cell and subsequent occurrence of continuinfusion technique into the inferior splenic pole in which ous release of regenerative stimulus. Because of this the transplanted cells flow from the spleen into the liver nature, uPA/SCID mice provide a hepatic environment via the portal system (n = 18). After the transplantation, that is more conducive to the engraftment of human uPA/SCID mice were treated with nafamostat mesilate hepatocytes and a selective advantage for transplanted to inhibit complement factors activated by human hepacells to proliferate (29) . An important property of uPA/ tocytes as described elsewhere (29) . SCID mice was recently reported to allow human hepatocytes transplanted into the liver of uPA/SCID mice to Determination of Replacement Ratio actively propagate while retaining their ability to produce and secrete human FIX (30) . From these data, it Blood samples were collected periodically from the tail vein, and the levels of human albumin were deter-was reasonably speculated that the propagated human hepatocytes can serve as a cell source for future hepato-mined with a Human Albumin ELISA Quantitation kit (Bethyl Laboratories, Montgomery, TX) to estimate the cyte-based therapies toward hemophilia B. The functional preservation of FIX production of the propagated status of proliferation and propagation of the transplanted human hepatocytes as previously described (29) . human hepatocytes encourages us to further assess functionalities for the production of other coagulation or For accurate determination of the ratio that transplanted human hepatocytes occupied in the recipient mouse liv-anticoagulation factors.
We hypothesized that propagated human hepatocytes ers (the replacement ratio), the harvested liver section were stained with antibodies against human-specific in the uPA/SCID mouse livers retained a normal gene cytokeratins 8 and 18 (hCK8/18), as described else-human liver tissues were serially diluted and used to generate calibrations. where (29) . The replacement ratios of the mouse liver that received human hepatocytes were calculated as the ratio of area occupied by hCK8/18-positive hepatocytes Statistical Analysis to the entire area examined immunohistochemical sec-Correlation coefficients between the repopulation rate tions of six lobes. and each gene expression were determined using Excel (Microsoft).
RNA Isolation and Quality Controls
Total RNA was extracted from the liver of the recipi-RESULTS ent mice with various stages of the replacement and normal human liver tissue samples by a RNeasy Mini Kit Propagation of Human Hepatocytes in uPA/SCID (QIAGEN, Hilden, Germany) following the manufactur-Mouse Liver er's instructions. Normal human liver tissue portions Human hepatocytes were transplanted to uPA/SCID were obtained from surgical specimens during liver surmice, which were sacrificed to excise the liver tissues at gery for metastatic liver tumors after acquiring a written various time periods after the transplantation with moniinformed consent for the experimental use of harvested toring the levels of blood human albumin. Using the colliver samples. DNase I was used to eliminate genomic lected liver samples, hCK8/18 immunostaing on the DNA contamination, and the concentration of the RNA liver sections was performed to accurately assess the was determined by UV spectrometry. All of the RNA replacement ratios with human hepatocytes as described samples used in this study had an absorbance ratio (260/ in Materials and Methods. As a result, the repopulation 280 nm) between 1.9 and 2.1, and the integrity of RNA ratios ranged from 0% to 98%, and the number of mice samples was confirmed by electrophoresis on a 1% agarin each repopulation category was 2, 4, 4, 4, and 4 ose gel.
in 0-20%, 21-40%, 41-60%, 61-80%, and 81-100%, respectively.
Reverse Transcription Coupled to Quantitative Real-Time PCR (Real-Time RT-PCR)
Selection of an Appropriate Reference Gene Total RNA (1 µg) was reverse-transcribed using oligo d(T)16 primers as described by the manufacturer The expressions of seven commonly used housekeeping genes (HKG) specific to human cells were evaluated (Omniscript RT Kit; QIAGEN). First-strand cDNA samples were subjected to quantitative PCR amplification in the recipient uPA/SCID mouse livers. Figure 1 shows that the raw expression levels of all seven HKGs using a StepOne Real-time PCR system (Applied Biosystems, Tokyo). For this experiment, we examined the increased in parallel to the replacement ratios. The correlation coefficiency with the replacement ratios of each following gene groups: 1) seven housekeeping reference genes, including glyceraldehyde-3-phosphate dehydro-gene was 0.68 for hGapdh; 0.86 for hActb; 0.72 for hPpia; 0.82 for hRpl4; 0.68 for hTfrc; 0.75 for hGusb; genase (Gapdh), β-actin (Actb), peptidylprolyl isomerase A (Ppia), ribosomal protein L4 (Rpl4), transferrin and 0.78 for hHprt1. When the replacement ratios exceeded 80%, the expression levels of all HKGs but receptor (Tfrc), β-glucuronidase (Gusb), and hypoxanthine phosphoribosyltransferase (Hprt1); 2) the genes of Hprt1 became higher than those of normal human liver samples. hGapdh expression levels in the repopulated five vitamin K-dependent coagulation factors, including prothrombin (F2), factor VII (F7), factor X (F10), pro-uPA/SCID livers were also observed to be beyond the levels of normal human livers at the repopulation ratio tein C (Prosc), and protein S (Pros1); and 3) factor VIII (F8) gene. TaqMan probes and primers for these genes as low as 40%. Eventually, hGapdh expression levels reached approximately sixfold of normal human liver were chosen from a TaqMan Gene Expression Assay (Applied Biosystems), and the information regarding levels when the repopulation ratios exceeded 80%. In contrast, gene expression levels of hActb failed to reach these primer sets are listed in Table 1 . All PCR analyses were performed using the following cycling conditions:
to comparable levels with normal human liver until the repopulation ratios were close to 100%. Under the con-10 min at 95°C, followed by 40 cycles of 15 s at 95°C, and 1 min at 60°C. The specificity of the primers was dition of varied gene expression levels of HKGs, it is important to select the most stably expressed HKG to verified by 2% agarose gel electrophoresis of the amplicons derived from naive human liver cDNAs. The PCR assess the expression of target human genes in the uPA/ SCID livers. For achieving this, Actb gene, which dem-primers used in this study were confirmed to be human specific and to have no cross-reactions with mouse-onstrated the best correlation coefficient with the replacement ratios, was selected as a reference normaliz-derived genes. For quantification of gene expression, the cDNAs derived from total RNA extracted from normal ing gene in the following gene expression analyses. Expression of Coagulation Factor Genes clotting factor production has been one of the major paradigms in liver regenerative medicine (18, 24) . In the Human-specific coagulation-related gene expression present study, we transplanted primary human hepatolevels were assessed on human hepatocyte-repopulated cytes to the liver of uPA/SCID mice and succeeded in uPA/SCID mouse livers. The genes analyzed were: vitapropagating the human hepatocytes in the mouse livers. min K-dependent coagulation factors (prothrombin, fac-We then investigated mRNA expression levels of tor VII, and factor X) and anticoagulation factors human-specific vitamin K-dependent coagulation factors (protein C and protein S), in addition to factor VIII. Raw (prothrombin, factor VII, and factor X), anticoagulation expression levels of all vitamin K-dependent coagulafactors (protein C and protein S), and factor VIII of the tion and anticoagulation factor genes showed a positive propagated hepatocytes at various stages of propagation. correlation with the repopulation ratios (Fig. 2) . The cor-
The results showed that mRNA expression levels per relation coefficient between the gene expression levels human hepatocyte of all the analyzed genes were mainand the repopulation ratios were 0.78, 0.74, 0.80, 0.80, tained through the propagation stage, indicating that the and 0.82 in F2, F7, F10, Prosc, and Pros1, respectively. uPA/SCID in-mouse hepatocyte propagation system is a The raw gene expression levels of all but F8 were viable method to propagate hepatocytes that are intact beyond the levels of the normal human liver samples in coagulation factor productions. (defined as 1.0) as the repopulation ratios increased. In Coagulation factors are produced mainly by hepatomarked contrast, F8 gene expression levels were less cytes, and the long-term synthesis of these factors from than 40% of normal human liver tissues even though the primary human hepatocytes in vitro have been recently repopulation ratios reached approximately 100%. The achieved by plating cells inside a 3D collagen gel matrix low levels of F8 gene expression failed to show a signiftogether with hormonally enriched culture medium icant correlation with the repopulation ratios (R = 0.66).
under chemically defined conditions (6) , indicating the In order to evaluate the gene expression levels per pivotal role of the extracellular environment for coagulahuman hepatocytes, the gene expression levels were nortion factor production. However, the current procedure malized by ACTB gene expression levels in each sample for the culture of primary hepatocytes appears to be dif- (Fig. 3) . As a result, normalized gene expression values ficult to support extensive cell proliferation (19) , still of all the analyzed coagulation-related factor genes showed remaining the problem of donor cell shortage unreconstant expression levels regardless of the repopulation solved. It is true that isolated hepatocytes could obtain ratios, demonstrating that the human hepatocytes in the proliferating ability and long-term survival in vitro by uPA/SCID livers stably express coagulation-related factor immortalization (26,34,35) or by selective culture of genes throughout the repopulation stages.
small hepatocyte population (27) , but there is no report DISCUSSION for studying the gene expression and production of coagulation factors including factor IX in these cell Propagation of primary human hepatocytes that possess hepatocyte-specific functionalities including blood types. On the other hand, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells have been inten-mice (29) or fumarylacetoacetate hydrolase −/− /recombination activating gene −/− /gamma chain of the interleukin-sively investigated as an attractive cell source for liver regenerative medicine, and differentiation technologies 2 receptor −/− (Fah −/− /Rag2 −/− /Il2rg −/− ) mice (2) . In our previous series of experiments, we found that of these stem cells into hepatocyte-like cells have been improved (12). In these circumstances, Basma et al. (3) human hepatocytes that were transplanted into the liver of uPA/SCID mouse perform active cell proliferation recently succeeded in differentiating human ES cells into hepatocytes-like cells maintaining the ability of leading to a nearly total repopulation of the liver (17, 29, 30, 36) and confirmed that those proliferated hepato-human factor VII production; however, the expression of coagulation factors other than factor VII were undoc-cytes maintained their ability to produce and secrete biologically functional human factor IX (30) . In addition to umented. In contrast to these in vitro cell culture systems, there are several in vivo hepatocyate propagating human hepatocytes, we also reported that primary canine hepatocytes could proliferate in uPA/SCID mouse liver systems, in which transplanted hepatocytes can efficiently proliferate in mouse livers, such as uPA/SCID while retaining functions for canine factor IX production Figure 2 were normalized with Actb gene expression levels in each human-chimeric mouse liver samples and plotted the repopulation ratios. (30) . At least, this in-mouse hepatocyte propagating sys-the expression levels of each gene by the levels of Actb. Results clearly showed that the gene expression levels tem is only an available and promising procedure for proliferating factor IX-producing hepatocytes at the of all analyzed coagulation and anticoagulation factors were stably maintained throughout the in-mouse repopu-present time. In this regard, it is important to clarify gene expression of other coagulation factors as well as lation process (Fig. 3) . Overall, the present study combined with our previous investigation (30) demonstrated factor IX in propagated human hepatocyte in uPA/SCID mouse liver, because to establish a method for hepato-that human primary hepatocytes were able to proliferate in the liver of uPA/SCID mice while retaining the cellu-cytes proliferation while retaining ability for coagulation factor production is indispensable for clinical cell ther-lar machinery for expressing F2, F7, F9, F10, Prosc, and Pros1. Since human hepatocyte propagated in uPA/ apy toward coagulation disorders.
We first assessed the expression levels of seven com-SCID mice are able to be isolated and purified by cellsorting technology (37), the present in-mouse propa-monly analyzed HKGs for human genome in the human hepatocyte-repopulated uPA/SCID mouse livers. The gated human hepatocytes is a feasible candidate cell source for a future therapeutic use toward coagulation gene expression levels of all seven HKGs increased in parallel to the increase of the repopulation ratio with a factor deficiencies. Furthermore, it was reported that efficient gene transduction into proliferated human high correlation coefficient, providing direct evidence that the transplanted human hepatocytes progressively hepatocytes in uPA/SCID mice was possible by using retroviral vector system (9), indicating the capability of proliferated in uPA/SCID mouse livers ( Fig. 1) . Interestingly, as for six out of seven HKGs analyzed, the gene obtaining hepatocytes that were genetically modified in vivo for the purpose to achieve higher expression levels expression levels of samples with more than 80% repopulation ratios surpassed the levels of normal human liv-of target proteins (15) .
In the present study, gene expression levels of F8 ers (arbitrarily defied as 1.0). It was reported that the upregulation of certain HKGs, especially Gapdh, was were remarkably low compared with those of other factors assessed. Even the liver samples showing the repop-closely associated with the events of DNA synthesis and cell division (1) . Such HKG upregulation profiles asso-ulation ratio more than 80% demonstrated only less than 40% of the control normal human liver tissues in human ciated with the hepatocyte proliferation were also observed in our previous works where hepatocyte prolif-F8 gene expression ( Fig. 2) . uPA/SCID mice have a characteristic to allow their own hepatocytes to be replaced eration in mouse livers was induced through the mode of compensatory regeneration (32) or direct hyperplasia by repopulated human hepatocytes, but all other intravital environment as well as nonparenchymal liver cells (28). These findings suggest that human hepatocytes progress their cell cycling events in the uPA/SCID livers remain predominantly host origin. As a result, it is likely that various signal cross-talks between repopulated while upregulating their structural proteins necessary for cell proliferation. Since HKGs are used as internal refer-human hepatocytes and host cells or humoral factors might become dysfunctional. For example, although ence gene(s) in gene expression analyses, it is essential to identify appropriate HKGs that are stably expressed hepatocytes require growth hormone (GH) for their active cell proliferation, human hepatocytes transplanted during examined pathological process. During the human hepatocyte repopulation process in the uPA/SCID livers, into mouse livers failed to be the target for such growth advantage because rodent GH is unable to bind to we found that the expression levels of Actb showed the highest correlation coefficient (R = 0.86) with the repop-human GH receptors (17). We have indeed established that this functional deficiency could be fully recovered ulation ratios among seven HKGs analyzed. Therefore, we concluded that the use of Actb for normalization of by administration of human GH to the human hepatocyte-repopulated uPA/SCID mice (17). The fact that gene expression levels was appropriate for obtaining accurate gene expression values.
human F8 gene expression level failed to increase may be explained by some mechanism similar to this type of To elucidate gene expression levels of coagulation and anticoagulation factors in propagating human hepa-interspecies incompatibility. An alternative possibility is that nonparenchymal cells, but hepatocytes, are the main tocytes in the liver of uPA/SCID mice was the main objective in this study. Using human-specific PCR prim-responsive cells for human factor VIII productions. Although the liver has been shown to be the major site ers, we found that raw expression levels of all genes increased in parallel to the increase of repopulation of factor VIII production as evidenced by previous liver transplantation clinical experiences (10,13,33), the pre-ratios with a high correlation coefficient. As the repopulation ratios increased higher than 80%, the expression cise type of liver cells contributing to factor VIII production has not been fully identified (4, 6, 8, 16) . In either levels of all genes except F8 surpassed the levels of normal human livers (Fig. 2) . We also investigated the gene the case, the present in-mouse hepatocyte propagation system using uPA/SCID mouse might be a valuable tool expression levels per human hepatocyte by normalizing 444 TATSUMI ET AL. A.; Heaton, N. D.; Rela, M.; Mieli-Vergani, G. Hepatofor the elucidation of cellular mechanism of factor VIII cyte transplantation for inherited factor VII deficiency. synthesis and production. In conclusion, the present study provides encouraging 8. Do, H.; Healey, J. F.; Waller, E. K.; Lollar, P. Expression evidence that uPA/SCID mouse system supported the of factor VIII by murine liver sinusoidal endothelial cells. J. Biol. Chem. 274:19587-19592; 1999. active proliferation of human hepatocytes while main-9. Emoto, K.; Tateno, C.; Hino, H.; Amano, H.; Imaoka, Y.;
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